Effects of high doses of corticosteroids on bone metabolism

被引:13
作者
Ardissone, P
Rota, E
Durelli, L
Limone, P
Isaia, GC
机构
[1] Univ Turin, Dipartimento Med Interna, I-10126 Turin, Italy
[2] Univ Turin, Dept Neurosci, I-10126 Turin, Italy
关键词
bone turnover; corticosteroids; multiple sclerosis;
D O I
10.1007/BF03343976
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of a chronic treatment with corticosteroids on bone are well known, but few data are available regarding the acute effect of these drugs on bone turnover. This study was aimed at evaluating the effects of high doses of corticosteroids administered for a short period on bone metabolism. We assessed 23 subjects (115 women and 8 men) suffering from multiple sclerosis and treated with methylprednisolone (11 9 iv for 10 days) followed by oral prednisone for 9 days; patients affected by diseases involving bone or treated during the previous 6 months with drugs influencing bone metabolism were excluded. We observed a significant decrease of ALP and bone glia protein (BGP), in these subjects, and a significant sudden increase of urinary calcium/creatinine and urinary cross-laps after 3 days of treatment. All of these parameters, except urinary calcium/creatinine, returned to basal levels after 30 days from the beginning of treatment (11 days after the interruption of corticosteroids administration). Serum phosphorus showed a significant decrease after 3 days of treatment, but returned to basal levels after 10 days. These data suggest that high doses of corticosteroids administered for a short period are able to induce an increase of bone resorption and a decrease of bone formation; moreover, bone turnover returns to basal levels when the treatment is stopped. (C)2002, Edlitrice Kurtis.
引用
收藏
页码:129 / 133
页数:5
相关论文
共 25 条
[1]   Corticosteroid-induced osteoporosis [J].
Adachi, JD .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1997, 313 (01) :41-49
[2]   STEROID-INDUCED FRACTURES AND BONE LOSS IN PATIENTS WITH ASTHMA [J].
ADINOFF, AD ;
HOLLISTER, JR .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (05) :265-268
[3]   Mechanisms of glucocorticoid action in bone: Implications to glucocorticoid-induced osteoporosis [J].
Canalis, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (10) :3441-3447
[4]   Fracture history and bone loss in patients with MS [J].
Cosman, F ;
Nieves, J ;
Komar, L ;
Ferrer, G ;
Herbert, J ;
Formica, C ;
Shen, V ;
Lindsay, R .
NEUROLOGY, 1998, 51 (04) :1161-1165
[5]  
COSMAN F, 1994, J BONE MINER RES, V9, P1097
[6]   A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update [J].
Eastell, R ;
Reid, DM ;
Compston, J ;
Cooper, C ;
Fogelman, I ;
Francis, RM ;
Hosking, DJ ;
Purdie, DW ;
Ralston, SH ;
Reeve, J ;
Russell, RGG ;
Stevenson, JC ;
Torgerson, DJ .
JOURNAL OF INTERNAL MEDICINE, 1998, 244 (04) :271-292
[7]   HORMONES AND THE INTESTINAL-ABSORPTION OF CALCIUM AND PHOSPHATE IN MAN [J].
GENNARI, C ;
BERNINI, M ;
NARDI, P ;
FUSI, L ;
NAMI, R ;
MONTAGNANI, M .
HORMONE RESEARCH, 1984, 20 (01) :13-21
[8]   EFFECTS OF PREDNISONE AND DEFLAZACORT ON MINERAL METABOLISM AND PARATHYROID-HORMONE ACTIVITY IN HUMANS [J].
GENNARI, C ;
IMBIMBO, B ;
MONTAGNANI, M ;
BERNINI, M ;
NARDI, P ;
AVIOLI, LV .
CALCIFIED TISSUE INTERNATIONAL, 1984, 36 (03) :245-252
[9]  
GODSCHALK MF, 1988, J BONE MINER RES, V3, P113
[10]   Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: Potential paracrine mechanisms of glucocorticoid-induced osteoporosis [J].
Hofbauer, LC ;
Gori, F ;
Riggs, BL ;
Lacey, DL ;
Dunstan, CR ;
Spelsberg, TC ;
Khosla, S .
ENDOCRINOLOGY, 1999, 140 (10) :4382-4389